THERATECHNOLOGIES INC (THTX)

Company Profile

Theratechnologies Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Montreal, Quebec and currently employs 89 full-time employees. Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The firm is focused on the development and commercialization of therapies addressing unmet medical needs. The company markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The firm's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. The company blocks viral entry into host cells while preserving normal immunologic function. The firm is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

Company Info

THERATECHNOLOGIES INC

2015 Peel Street, 11th Floor

MONTREAL QUEBEC H3A 1T8

P: 15143367800

CEO: Paul Levesque

Employees: 89

Website: https://www.theratech.com/